3 ASX shares brokers have named as buys

These ASX shares have been named as buys…

| More on:
Man presses green buy button and red sell button on a graph.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

If you have room in your portfolio for some new additions, then you may want to take a closer look at the ASX shares listed below.

All three have recently been tipped as buys by brokers. Here's what analysts are saying about them right now:

Altium Limited (ASX: ALU)

Altium is an electronic design software provider. It is best-known for its Altium Designer and Altium 365 platforms. These platforms are regarded as the best in the industry and are used by many of the world's largest companies such as BAE Systems, Microsoft, and Tesla. Altium appears well-placed for growth over the next decade thanks to the internet of things and artificial intelligence booms. These are driving strong demand for electronic design software.

Jefferies is a big fan of Altium and has a buy rating and $48.83 price target on its shares. This is notably higher than the current Altium share price of $37.07.

REA Group Limited (ASX: REA)

REA Group is the dominant player in real estate listings in the Australian market. It looks well-placed for growth in the coming years thanks to the improving housing market, new revenue streams, acquisitions, price increases, and its international operations.

Goldman Sachs is very bullish on REA Group. Its analysts currently have a buy rating and $193.00 price target on its shares. This compares to the latest REA Group share price of $147.07.

ResMed Inc. (ASX: RMD)

ResMed is a sleep treatment-focused medical device company. Thanks to its industry-leading products, growing software business, and the increasing awareness of sleep disorders, it has been growing at a strong rate for a good number of years. Pleasingly, it still has a significant market opportunity to grow into and also looks well-placed to benefit from the shift to home healthcare.

Morgans is positive on ResMed's outlook. The broker currently has an add rating and $40.80 price target on the company's shares. The ResMed share price last traded at $32.66.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns and has recommended Altium. The Motley Fool Australia has recommended REA Group Limited and ResMed Inc. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Growth Shares

A young bank customer wearing a yellow jumper smiles as she checks her bank balance on her phone.
Growth Shares

The ASX 200 stock with 'compelling growth opportunities', and a new ticker code!

Fund managers are saying good things about this tech company.

Read more »

A female ASX investor looks through a magnifying glass that enlarges her eye and holds her hand to her face with her mouth open as if looking at something of great interest or surprise.
Growth Shares

2 ASX growth shares Aussie investors should watch in 2025

Analysts have good things to say about these growth shares.

Read more »

A woman with strawberry blonde hair has a huge smile on her face and fist pumps the air having seen good news on her phone.
Growth Shares

5 Australian stocks to hold for the next decade

Analysts have buy ratings on these shares. Here's why they could be top buy and hold picks.

Read more »

a man looks down at his phone with a look of happy surprise on his face as though he is thrilled with good news.
Growth Shares

Top ASX shares to buy right now with $2,000

Analysts think these shares would be good options for an investment this month.

Read more »

Growth Shares

3 exciting ASX 200 growth shares to buy and hold for a decade

These growth shares have been given buy ratings by analysts.

Read more »

View of a business man's hand passing a $100 note to another with a bank in the background.
Growth Shares

Invest $10,000 into these ASX 200 shares in January

Market-beating returns could be on offer from these shares this year according to analysts.

Read more »

A happy young girls lies in the grass with her father, smiling at the prospects of a bright future.
Growth Shares

I think these 2 ASX shares are ideal for growth investors

Technology is an exciting sector to find opportunities.

Read more »

A young boy sits on his father's shoulders as they flex their muscles at sunrise on a beach
Growth Shares

2 ASX 300 shares I'm very excited about for 2025

2025 could be a good year for these stocks.

Read more »